Residual tumor cells are unique cellular targets in glioblastoma

Annals of Neurology

Volumn 68, Issue 2, 2010, Pages 264-269

  Glas, Martin ^a   Rath, Barbara H ^a   Simon, Matthias ^a   Reinartz, Roman ^a   Schramme, Anja ^a   Trageser, Daniel ^a   Eisenreich, Ramona ^a   Leinhaas, Anke ^a   Keller, Mihaela ^a   Schildhaus, Hans Ulrich ^a   Garbe, Stephan ^a   Steinfarz, Barbara ^a   Pietsch, Torsten ^a   Steindler, Dennis A ^b   Schramm, Johannes ^a   Herrlinger, Ulrich ^a   Brüstle, Oliver ^a   Scheffler, Björn ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STEM CELL; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR CELL; BRAIN NEOPLASMS; CELL SEPARATION; CULTURE TECHNIQUE; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL CULTURE; TUMOR INVASION;

ADULT; AGED; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; TUMOR CELLS, CULTURED;

EID: 77955300349     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22036     Document Type: Article

References (20)

1. Mitchell P, Ellison DW, Mendelow AD. Surgery for malignant gliomas: mechanistic reasoning and slippery statistics. Lancet Neurol 2005;4:413-422. (Pubitemid 40834272)
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996.
3. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392-401.
4. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003;3:489-501.
5. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
6. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760. (Pubitemid 44949604)
7. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403. (Pubitemid 43668737)
8. Louis D, Ohgaki H, Wiestler O, et al. WHO classification of tumours of the central nervous system. Lyon, France: IARC Press, 2007.
9. Hoelzinger DB, Mariani L, Weis J, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005;7:7-16. (Pubitemid 40209466)
10. Van Meter T, Dumur C, Hafez N, et al. Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets. Diagn Mol Pathol 2006;15:195-205. (Pubitemid 44813658)
11. Mangiola A, Lama G, Giannitelli C, et al. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res 2007;13:6970-6977. (Pubitemid 350276877)
12. Scheffler B, Walton NM, Lin DD, et al. Phenotypic and functional characterization of adult brain neuropoiesis. Proc Natl Acad Sci U S A 2005;102:9353-9358. (Pubitemid 40923567)
13. Beier D, Rohrl S, Pillai DR, et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 2008;68: 5706-5715.
14. Glas M, Happold C, Rieger J, et al. Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. J Clin Oncol 2009;27:1257-1261.
15. Sathornsumetee S, Reardon DA, Desjardins A, et al. Molecularly targeted therapy for malignant glioma. Cancer 2007;110:13-24.
16. Nakada M, Nakada S, Demuth T, et al. Molecular targets of glioma invasion. Cell Mol Life Sci 2007;64:458-478.
17. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008;8:755-768.
18. Piccirillo SG, Combi R, Cajola L, et al. Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene 2009;28:1807-1811.
19. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-1068.
20. Pillay V, Dass CR, Choong PF. The urokinase plasminogen activator receptor as a gene therapy target for cancer. Trends Biotechnol 2007;25:33-39. (Pubitemid 46001467)